Impact of prior intravenous thrombolysis on first-line thrombectomy strategy. A secondary analysis of the VECTOR trial. | ClinicLens
Whether prior intravenous thrombolysis (IVT) modifies the relative efficacy of first-line thrombectomy strategies remains uncertain, and no randomised trial has specifically addressed this question. Leveraging the randomised design of the VECTOR trial, a multicentre trial compari
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.